The PARTNER Study

The Partner Study

This study will investigate the impact of the oral medication sotagliflozin on glucose control in people with Type 1 diabetes.

The PARTNER Study

The Partner Study

This research study will evaluate a drug called sotagliflozin, which may improve glucose levels, protect the kidneys and heart, and offer the potential for weight loss. However, sotagliflozin use in type 1 diabetes (T1D) can be associated with diabetic ketoacidosis (DKA).
The aim of this study is to monitor glucose and ketone levels concurrently utilising continuous glucose and ketone sensors, combined with an education program to reduce the risk of DKA.
This study will aid in the prevention of DKA and potentially allow for the use of this drug in T1D.

Participation in this study will involve:

  • 30 weeks participation
  • 6-8 on-site clinic visits
  • Wearing 2 sensors on the body monitored continuously via phone apps

Become a participant!
If you are:

  • over 18 years old
  • living with Type 1 Diabetes for at least 1 year

Then you may be a good match for this study

Meet Kim Henshaw who is a participant in type 1 diabetes technology research at the DTRG. Watch Kim explain what it means to her to be a participant in this important area of research.

Get involved

Please contact the Research Group Leader to discuss your options.

    The PARTNER Study

    The Partner Study

    This research study will evaluate a drug called sotagliflozin, which may improve glucose levels, protect the kidneys and heart, and offer the potential for weight loss. However, sotagliflozin use in type 1 diabetes (T1D) can be associated with diabetic ketoacidosis (DKA).
    The aim of this study is to monitor glucose and ketone levels concurrently utilising continuous glucose and ketone sensors, combined with an education program to reduce the risk of DKA.
    This study will aid in the prevention of DKA and potentially allow for the use of this drug in T1D.

    Participation in this study will involve:

    • 30 weeks participation
    • 6-8 on-site clinic visits
    • Wearing 2 sensors on the body monitored continuously via phone apps

    Become a participant!
    If you are:

    • over 18 years old
    • living with Type 1 Diabetes for at least 1 year

    Then you may be a good match for this study

    Meet Kim Henshaw who is a participant in type 1 diabetes technology research at the DTRG. Watch Kim explain what it means to her to be a participant in this important area of research.

    Get involved

    Please contact the Research Group Leader to discuss your options.